Cargando…
Choosing pharmacotherapy for ILD in patients with connective tissue disease
Interstitial lung disease (ILD) is a well-recognised complication of several connective tissue diseases (CTD). This article outlines the various treatment options for the most common CTD-ILDs and discuss the ongoing research in this field. https://bit.ly/39NHwx6
Autores principales: | Wu, Zhe, Molyneaux, Philip L. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
European Respiratory Society
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8753625/ https://www.ncbi.nlm.nih.gov/pubmed/35035571 http://dx.doi.org/10.1183/20734735.0114-2021 |
Ejemplares similares
-
Expert Opinion Guidance on the Detection of Early Connective Tissue Diseases in Interstitial Lung Disease
por: Namas, Rajaie, et al.
Publicado: (2023) -
Gastrointestinal stromal tumor mesenchymal neoplasms: the offspring that choose the wrong path
por: Machairiotis, Nikolaos, et al.
Publicado: (2013) -
Al-Hijamah (Prophetic Wet Cupping Therapy) is a Novel Adjuvant Treatment for Viral Hepatitis That Excretes Viral Particles and Excess Ferritin Percutaneously, Synergizes Pharmacotherapy, Enhances Antiviral Immunity and Helps Better HCC Prevention and Treatment: A Novel Evidence-Based Combination with Prophetic Medicine Remedies
por: El Sayed, Salah Mohamed
Publicado: (2023) -
Pharmacotherapies for COPD
por: Ejiofor, Stan, et al.
Publicado: (2013) -
Ipilimumab Pharmacotherapy in Patients with Metastatic Melanoma
por: Jeter, Joanne M., et al.
Publicado: (2012)